...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >FORMULATION AND EVALUATION OF METRONIDAZOLE MICROSPHERES-LOADED BIOADHESIVE VAGINAL GEL
【24h】

FORMULATION AND EVALUATION OF METRONIDAZOLE MICROSPHERES-LOADED BIOADHESIVE VAGINAL GEL

机译:甲硝唑微球载生物胶的制备与评价

获取原文

摘要

Objectives: The objective of the present work is to develop and characterize metronidazole microsphere-loaded bioadhesive vaginal gel to ensure longer residence time at the infection site, providing a favorable release profile for the drug. Methods: Microsphere was prepared by solvent evaporation method in various ratios of metronidazole to poly-ε-caprolactone (PCL). Physicochemical evaluation of microspheres includes determination of solubility in simulated vaginal fluid, partition coefficient (n-octanol/citrate phosphate buffer pH 4.5), particle size distribution, entrapment efficiency, X-ray diffraction, and surface morphology by scanning electron microscopy (SEM). Drug excipient compatibility was established by Fourier transform infrared and differential scanning calorimetry studies. Bioadhesive gel was prepared using Carbopol 934P and HPMC K4M in various concentrations, and methyl paraben was used as a preservative. The pH was adjusted with triethanolamine which resulted in a translucent gel. The optimized metronidazole microsphere formulation was dispersed into the gel base. Microspheres in gel formulations were evaluated for pH, viscosity, spreadability, drug content, and gelling strength. Ex vivo mucoadhesive strength of the gel was determined on goat vaginal mucosa. In vitro drug release study was performed using cellophane membrane. Results: The optimized batch of microsphere F4 (drug-polymer ratio 1:4) showed entrapment efficiency of 72.62±3.66%, solubility of 1.5 mg/ml, and partition coefficient of 0.12. Particle size of all the formulations was observed below 100 μm. Regular and spherical particles were observed in the SEM photomicrographs. The optimized gel formulation G5 (Carbopol and HPMC at 1: 0.25 ratio) showed viscosity of 7538 cps at 100 RPM, gel strength recorded as 35 secobds for a 1000.00 mg load, and spreadability of 4.6 g.cm/seconds. G5 showed 82.4% drug release at 10.0 hrs and mucoadhesive strength of 6.5±1.2 g. Conclusion: The study results suggest that metronidazole-loaded PCL microsphere in mucoadhesive gel would provide a mean for sustained treatment of vaginal infections. Keywords: Microsphere, Metronidazole, Bioadhesive vaginal gel.
机译:目的:本研究的目的是开发和表征甲硝唑微球负载的生物粘附阴道凝胶,以确保在感染部位的停留时间更长,从而为药物提供有利的释放特性。方法:采用溶剂蒸发法制备了不同比例的甲硝唑与聚ε-己内酯(PCL)的微球。微球的理化评估包括通过扫描电子显微镜(SEM)确定模拟阴道液中的溶解度,分配系数(正辛醇/柠檬酸磷酸盐缓冲液pH 4.5),粒度分布,包封效率,X射线衍射和表面形态。通过傅立叶变换红外和差示扫描量热法研究建立了药物赋形剂的相容性。使用各种浓度的Carbopol 934P和HPMC K4M制备生物粘附凝胶,并使用对羟基苯甲酸甲酯作为防腐剂。用三乙醇胺调节pH,得到半透明的凝胶。将优化的甲硝唑微球制剂分散到凝胶基质中。评价凝胶制剂中的微球的pH,粘度,铺展性,药物含量和胶凝强度。在山羊阴道粘膜上测定凝胶的离体粘膜粘附强度。使用玻璃纸膜进行体外药物释放研究。结果:优化的一批微球F4(药物与聚合物的比例为1:4)的包封率为72.62±3.66%,溶解度为1.5 mg / ml,分配系数为0.12。在低于100μm下观察到所有制剂的粒度。在SEM显微照片中观察到规则和球形颗粒。优化的凝胶制剂G5(Carbopol和HPMC的比例为1:0.25)在100 RPM下的粘度为7538 cps,对于1000.00 mg的负载,凝胶强度记录为35 secobds,铺展性为4.6 g.cm/s。 G5在10.0小时显示82.4%的药物释放,粘膜粘附强度为6.5±1.2 g。结论:该研究结果表明,在粘膜粘附凝胶中负载甲硝唑的PCL微球可为持续治疗阴道感染提供一种手段。关键字:微球,甲硝唑,生物粘附性阴道凝胶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号